Skip to main content
. Author manuscript; available in PMC: 2023 Nov 13.
Published in final edited form as: Lancet Diabetes Endocrinol. 2023 Sep 11;11(10):731–742. doi: 10.1016/S2213-8587(23)00223-1

Table 1. Hazard ratios for all-cause and cause-specific mortality according to age at diagnosis of diabetes with adjustment for conventional risk factors.*.

HR (95% CI) adjusted for...
No. of events Age and sex Age, sex, and smoking Age, sex, smoking, and other risk factors**
All-cause mortality
No Diabetes 153068 1 (Ref) 1 (Ref) 1 (Ref)
30 to <40 yrs 676 2.69 (2.43, 2.97) 2.74 (2.49, 3.02) 2.64 (2.41,2.90)
40 to <50 yrs 2070 2.26 (2.08, 2.45) 2.33 (2.14, 2.53) 2.24 (2.06, 2.43)
50 to <60 yrs 4197 1.84 (1.72, 1.97) 1.87 (1.75, 1.99) 1.79 (1.69, 1.90)
60 to <70 yrs 4125 1.57 (1.47, 1.67) 1.60 (1.51,1.70) 1.55 (1.46, 1.64)
≥70 yrs 3026 1.39 (1.29, 1.51) 1.43 (1.33, 1.55) 1.41 (1.31,1.53)
Per decade earlier 167162 1.14 (1.08, 1.19) 1.13 (1.08, 1.19) 1.13 (1.07, 1.19)
P-value*** <0.0001 <0.0001 <0.0001
I2 (95% CI) 67 (59, 74) 68 (60, 74) 67 (60, 74)
CVD mortality
No Diabetes 53857 1 (Ref) 1 (Ref) 1 (Ref)
30 to <40 yrs 278 4.20 (3.57, 4.94) 4.26 (3.65, 4.99) 3.93 (3.41,4.53)
40 to <50 yrs 821 3.19 (2.80, 3.64) 3.31 (2.90, 3.76) 2.93 (2.60, 3.30)
50 to <60 yrs 1564 2.31 (2.10, 2.53) 2.36 (2.16, 2.58) 2.10 (1.94, 2.27)
60 to <70 yrs 1580 1.95 (1.78, 2.14) 1.98 (1.82, 2.17) 1.81 (1.67, 1.97)
≥70 yrs 1251 1.50 (1.35, 1.67) 1.54 (1.38, 1.71) 1.48 (1.33, 1.65)
Per decade earlier 59351 1.19 (1.11, 1.27) 1.19 (1.11, 1.27) 1.19 (1.11, 1.28)
P-value*** <0.0001 <0.0001 <0.0001
I2 (95% CI) 58 (47, 67) 59 (48, 67) 59 (48, 67)
Cancer mortality
No Diabetes 53217 1 (Ref) 1 (Ref) 1 (Ref)
30 to <40 yrs 124 1.55 (1.30, 1.85) 1.56 (1.31,1.86) 1.48 (1.24, 1.76)
40 to <50 yrs 433 1.28 (1.16, 1.42) 1.32 (1.19, 1.45) 1.25 (1.13, 1.37)
50 to <60 yrs 1211 1.33 (1.22, 1.46) 1.37 (1.25, 1.49) 1.35 (1.26, 1.44)
60 to <70 yrs 1178 1.27 (1.17, 1.38) 1.29 (1.19, 1.40) 1.28 (1.19, 1.37)
≥70 yrs 593 1.29 (1.18, 1.42) 1.32 (1.20, 1.44) 1.31 (1.20, 1.42)
Per decade earlier 56756 0.95 (0.88, 1.02) 0.95 (0.88, 1.02) 0.94 (0.88, 1.02)
P-value*** 0.176 0.160 0.128
I2 (95% CI) 26 (2, 44) 24 (0, 43) 24 (0, 43)
Non-CVD, non-cancer mortality
No Diabetes 35986 1 (Ref) 1 (Ref) 1 (Ref)
30 to <40 yrs 250 3.99 (3.50, 4.55) 4.04 (3.54, 4.60) 3.90 (3.42, 4.45)
40 to <50 yrs 701 3.24 (2.88, 3.64) 3.34 (2.96, 3.76) 3.31 (2.95, 3.71)
50 to <60 yrs 1224 2.31 (2.09, 2.54) 2.37 (2.15, 2.60) 2.38 (2.16, 2.64)
60 to <70 yrs 1137 1.84 (1.67, 2.02) 1.87 (1.70, 2.05) 1.88 (1.71,2.06)
≥70 yrs 861 1.66 (1.48, 1.87) 1.71 (1.52, 1.93) 1.76 (1.56, 1.98)
Per decade earlier 40159 1.18 (1.10, 1.27) 1.18 (1.09, 1.27) 1.16 (1.08, 1.25)
P-value*** <0.0001 <0.0001 <0.0001
I2 (95% CI) 50 (35, 61) 51 (36, 62) 50 (36, 62)
*

Analyses based on ERFC and UK Biobank, including 92 cohorts and 1,132,277 participants with complete information on age at diagnosis of diabetes, age, sex, smoking and other risk factors.

**

Other risk factors were body mass index, systolic blood pressure and total cholesterol.

***

P-value for log-linear analyses per decade earlier.